PI
ALDX icon

PEAK6 Investments’s Aldeyra Therapeutics ALDX Stock Holding History

PEAK6 Investments’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,500
Closed -$62.9K – 4006
2023
Q2 		$62.9K Buy
+7,500
New +$73.9K ﹤0.01% 3389
2022
Q3 		– Sell
-7,500
Closed -$62.9K – 4875
2022
Q2 		$62.9K Buy
+7,500
New +$25.8K ﹤0.01% 5448

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PEAK6 Investments's ALDX Position: Q3 2023 in Review

PEAK6 Investments sold out of Aldeyra Therapeutics (ALDX) in Q3 2023, closing a stake of 5,500 shares — an estimated $46.1K sold.

PEAK6 Investments first reported a position in ALDX in Q2 2022 and held it in 3 quarters. The position peaked at $109K in Q1 2023. 120 funds tracked by Wall St. Rank hold ALDX as of Q3 2023.

  • PEAK6 Investments reported no remaining Aldeyra Therapeutics position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 5,500 Aldeyra Therapeutics shares in Q3 2023, an estimated $46.1K.
  • PEAK6 Investments first reported a position in Aldeyra Therapeutics in Q2 2022 and held it in 3 quarters.
  • PEAK6 Investments's Aldeyra Therapeutics position peaked at $109K in Q1 2023.
  • 120 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.